drugset / Trial / NCT00495885

Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus

NCT00495885

Phase 3 Completed 848 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess efficacy and safety of volinanserin in the population of patients complaining of sleep maintenance insomnia. The objective of the substudy is to assess glycemic control in the subgroup of patients with type II diabetes mellitus.

Timeline

Start
2007-06
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Volinanserin Small molecule 2 mg Oral